Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 397 of 1,261

  1. US 10780163

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  2. US 10780145

    In situ forming hydrogel and method using same

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  3. US 10780147

    Vault complexes for cytokine delivery

    United States Government as represented by the Department of Veterans Affairs · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  4. US 10781169

    Method of synthesis of an ionizable cationic lipid

    ARCTURUS THERAPEUTICS, INC. · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  5. US 10781181

    N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  6. US 10781183

    Small molecule inducers of reactive oxygen species and inhibitors of mitochondrial activity

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  7. US 10780067

    Endoxifen for local transdermal therapy to the breast

    Northwestern University · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  8. US 10780155

    Streptococcal GlcNac-lacking gylcopolypeptides, cell wall carbohydrates, Streptococcus vaccines, and methods for making and using them

    The Regents of the University of California · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  9. US 10780095

    Compositions and methods for treating disorders of circadian and diurnal rhythms using prokineticin 2 agonists and antagonists

    The Regents of the University of California · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  10. US 10780166

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  11. US 10780058

    Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

    UNIVERSITY OF CONNECTICUT · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  12. US 10780096

    Pyrrolobenzodiazepine-antibody conjugates

    ADC THERAPEUTICS SA · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  13. US 10781189

    1,2,4-Oxadiazole and thiadiazole compounds as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  14. US 10781218

    Substituted inhibitors of menin-MLL and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  15. EP 3708579

    CLAUDIN-6-SPEZIFISCHE IMMUNREZPTOREN UND T-ZELL-EPITOPE

    BIONTECH CELL & GENE THERAPIES GMBH [DE] · Granted Sep 16, 2020 · Expires Sep 11, 2040

    granted

  16. US 10772828

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  17. US 10772854

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  18. US 10774122

    ERG targeted therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  19. US 10772897

    Method for on-demand contraception

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  20. US 10774092

    ULK1 inhibitors and methods using same

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  21. US 10774080

    Pyrimidine compound as JAK kinase inhibitor

    Theravance Biopharma R&D IP, LLC · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  22. US 10774056

    Substituted piperazines as selective HDAC1,2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  23. US 10772972

    Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  24. US 10772913

    Administration of kynurenine depleting enzymes for tumor therapy

    The Board of Regents of the University of Texas System · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.